The Scientist

» neurodegeneration

Most Recent

image: How Microbes May Influence Our Behavior

How Microbes May Influence Our Behavior

By | September 1, 2017

Researchers are piecing together the links between the gut microbiome and mental health.

3 Comments

image: Do Microbes Trigger Alzheimer’s Disease?

Do Microbes Trigger Alzheimer’s Disease?

By | September 1, 2017

The once fringe idea is gaining traction among the scientific community.

6 Comments

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.

0 Comments

Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.

0 Comments

image: A Potential Remedy for the Aging Brain

A Potential Remedy for the Aging Brain

By | August 8, 2017

In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease. 

0 Comments

image: Second-Ever ALS Drug Approved

Second-Ever ALS Drug Approved

By | May 8, 2017

Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.

1 Comment

image: Opinion: Canine Models for Alzheimer’s

Opinion: Canine Models for Alzheimer’s

By | March 1, 2017

For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes. 

7 Comments

image: Toward Treating Alzheimer’s Disease with Brain Waves

Toward Treating Alzheimer’s Disease with Brain Waves

By | December 7, 2016

In a mouse model, researchers mitigated three Alzheimer’s disease–associated symptoms by stimulating gamma waves with light.

2 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Alzheimer’s Immunotherapy Pioneer Dies

Alzheimer’s Immunotherapy Pioneer Dies

By | October 11, 2016

Dale Schenk, who worked to develop a vaccine for Alzheimer’s disease, has passed away at age 59.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Judge Recommends Ruling to Block Internet Access to Sci-Hub
  3. Opinion: Microbiology Needs More Math
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech